Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine

N Fujiwara, SL Friedman, N Goossens, Y Hoshida - Journal of hepatology, 2018 - Elsevier
Patients who develop chronic fibrotic liver disease, caused by viral or metabolic aetiologies,
are at a high risk of developing hepatocellular carcinoma (HCC). Even after complete HCC …

Hepatitis B virus-associated hepatocellular carcinoma

GEM Rizzo, G Cabibbo, A Craxì - Viruses, 2022 - mdpi.com
Hepatitis B virus (HBV) is DNA-based virus, member of the Hepadnaviridae family, which
can cause liver disease and increased risk of hepatocellular carcinoma (HCC) in infected …

Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy

JH Kim, YD Kim, M Lee, BG Jun, TS Kim, KT Suk… - Journal of …, 2018 - Elsevier
Background & Aims Recently, the PAGE-B score and Toronto HCC risk index (THRI) have
been developed to predict the risk of hepatocellular carcinoma (HCC) in Caucasian patients …

An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B

HY Kim, P Lampertico, JY Nam, HC Lee, SU Kim… - Journal of …, 2022 - Elsevier
Background & Aims Several models have recently been developed to predict risk of
hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). Our aims were to …

Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B

YC Hsu, TCF Yip, HJ Ho, VWS Wong, YT Huang… - Journal of …, 2018 - Elsevier
Background & Aims The risk of hepatocellular carcinoma (HCC) during antiviral therapy in
patients with chronic hepatitis B (CHB) is inadequately predicted by the scores built from …

Risk stratification and early detection biomarkers for precision HCC screening

YT Lee, N Fujiwara, JD Yang, Y Hoshida - Hepatology, 2023 - journals.lww.com
Hepatocellular carcinoma (HCC) mortality remains high primarily due to late diagnosis as a
consequence of failed early detection. Professional societies recommend semi‐annual HCC …

[HTML][HTML] Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection

CL Lin, JH Kao - Clinical and Molecular Hepatology, 2023 - ncbi.nlm.nih.gov
Hepatitis B virus (HBV) is responsible for more than 50% of hepatocellular carcinoma (HCC)
in HBV hyperendemic areas, such as the Asia-Pacific region. Several hepatitis B viral factors …

Prevention of hepatitis B virus–related hepatocellular carcinoma

ASF Lok - Gastroenterology, 2004 - Elsevier
The most effective means of preventing hepatitis B virus (HBV)-related hepatocellular
carcinoma (HCC) is to prevent HBV infection via global vaccination of infants. Universal …

Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta …

ZH Huang, GY Lu, LX Qiu, GH Zhong, Y Huang… - BMC cancer, 2022 - Springer
Background Long-term antiviral treatments are associated with a significantly lower
hepatocellular carcinoma (HCC) incidence in chronic hepatitis B (CHB) patients by reducing …

Clinical utility of hepatocellular carcinoma risk scores in chronic hepatitis B

T Voulgaris, M Papatheodoridi, P Lampertico… - Liver …, 2020 - Wiley Online Library
Background Several risk scores have been recently developed to predict hepatocellular
carcinoma (HCC) in chronic hepatitis B (CHB) patients. We systematically assessed the …